Physician profile
Paul A Peller
NPI 1740243674
$12,600.00
in general payments reported to CMS, 2019-2025
57 companies · $2,619 in 2025
The $2,619 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,351 · 2020: $427 · 2021: $1,061 · 2022: $2,042 · 2023: $2,913 · 2024: $2,187 · 2025: $2,619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,425 · Education: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,424.90 |
| Education | $294.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,408.24 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $1,374.75 | 2019-2025 | Erleada, Akeega, Rybrevant |
| Dendreon Pharmaceuticals LLC | $1,151.23 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $952.50 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $869.08 | 2023-2025 | Orgovyx, Gemtesa |
| Teleflex LLC | $567.60 | 2021-2025 | Urolift, Barrigel |
| Accord Healthcare, INC. | $502.73 | 2023-2025 | |
| Abbvie INC. | $481.35 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $441.61 | 2019-2024 | Xiaflex, Aveed, Edex |
| Antares Pharma, INC. | $424.22 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Coloplast Corp | $285.44 | 2019-2024 | Speedicath |
| Pfizer INC. | $271.30 | 2019-2025 | |
| Myovant Sciences INC. | $251.11 | 2021-2022 | |
| Urovant Sciences INC | $246.93 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $219.55 | 2019-2025 | Adstiladrin, Firmagon |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Peller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.